Alcon to acquire u.s. commercialization rights to ophthalmic eye drop simbrinza

Geneva--(business wire)--alcon to acquire u.s. commercialization rights to ophthalmic eye drop simbrinza
ALC Ratings Summary
ALC Quant Ranking